新型冠状病毒肺炎发病机制、预防和治疗的分子机制：总结 2022 年的研究结果。
Molecular Mechanisms of Pathogenesis, Prevention, and Therapy of COVID-19: Summarizing the Results of 2022.
机构信息
Laboratory for Immunology of Inflammation, Institute of Immunology and Physiology of the Ural Branch of the Russian Academy of Sciences (IIP UB RAS), 620049 Ekaterinburg, Russia.
出版信息
Int J Mol Sci. 2023 Nov 8;24(22):16073. doi: 10.3390/ijms242216073.
Abstract
The aim of this Special Issue is to analyze the key patterns of the 2019 coronavirus disease pandemic (COVID-19), the biology of SARS-CoV-2 (severe-acute-respiratory-syndrome-related coronavirus 2, formerly 2019-nCoV), and the characteristics of the human body's response to the invasion of this virus [...].
摘要
本特刊旨在分析 2019 年冠状病毒病（COVID-19）大流行的关键模式、SARS-CoV-2（严重急性呼吸系统综合征相关冠状病毒 2，以前称为 2019-nCoV）的生物学特性以及人体对这种病毒入侵的反应特征[... ]。
相似文献
1
Molecular Mechanisms of Pathogenesis, Prevention, and Therapy of COVID-19: Summarizing the Results of 2022.新型冠状病毒肺炎发病机制、预防和治疗的分子机制：总结 2022 年的研究结果。
Int J Mol Sci. 2023 Nov 8;24(22):16073. doi: 10.3390/ijms242216073.
2
COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses.COVID-19 大流行：从感染、免疫和病理反应角度看新型冠状病毒的发病机制——多学科视角。
Front Immunol. 2022 Aug 26;13:978619. doi: 10.3389/fimmu.2022.978619. eCollection 2022.
3
[Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].[2019冠状病毒病及严重急性呼吸综合征冠状病毒2的诊断、治疗、控制与预防：回归未来]
Sheng Wu Gong Cheng Xue Bao. 2020 Apr 25;36(4):571-592. doi: 10.13345/j.cjb.200115.
4
The Pandemic of Coronavirus Disease 2019 (COVID-19).2019 年冠状病毒病（COVID-19）大流行。
Curr Mol Med. 2022;22(9):761-765. doi: 10.2174/1566524021666211117145216.
5
Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.严重急性呼吸综合征冠状病毒 2 在人呼吸道上皮细胞中的复制。
J Virol. 2020 Jul 16;94(15). doi: 10.1128/JVI.00957-20.
6
The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.SARS-CoV-2 传播的独特特征：与 SARS-CoV、MERS-CoV 和 2009 年 H1N1 大流行性流感病毒的比较。
Rev Med Virol. 2021 Mar;31(2):e2171. doi: 10.1002/rmv.2171. Epub 2020 Sep 18.
7
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染：综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
8
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）：病毒结构与宿主反应概述
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):407-412. doi: 10.1016/j.dsx.2020.04.020. Epub 2020 Apr 18.
9
Nanobiosensors for the Detection of Novel Coronavirus 2019-nCoV and Other Pandemic/Epidemic Respiratory Viruses: A Review.用于检测新型冠状病毒 2019-nCoV 和其他大流行/流行性呼吸道病毒的纳米生物传感器：综述。
Sensors (Basel). 2020 Nov 18;20(22):6591. doi: 10.3390/s20226591.
10
SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines.严重急性呼吸综合征冠状病毒2：既往冠状病毒、免疫反应及疫苗研发
Bol Med Hosp Infant Mex. 2020;77(5):252-261. doi: 10.24875/BMHIM.20000191.
引用本文的文献
1
Exploring the Pathophysiology of Long COVID: The Central Role of Low-Grade Inflammation and Multisystem Involvement.探索长新冠的病理生理学：低度炎症和多系统受累的核心作用。
Int J Mol Sci. 2024 Jun 9;25(12):6389. doi: 10.3390/ijms25126389.
本文引用的文献
1
The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒发展的终结还是新时代：导致重症冠状病毒病（COVID-19）的基因变体以及临床实践中最常用疫苗的临床疗效
Vaccines (Basel). 2023 Jun 30;11(7):1181. doi: 10.3390/vaccines11071181.
2
New-onset neurodegenerative diseases as long-term sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis.新型神经退行性疾病作为 SARS-CoV-2 感染的长期后遗症：系统评价和荟萃分析。
J Med Virol. 2023 Jul;95(7):e28909. doi: 10.1002/jmv.28909.
3
ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature.肌痛性脑脊髓炎/慢性疲劳综合征（ME/CFS）与长期新冠有相似症状和生物学异常：文献路线图
Front Med (Lausanne). 2023 Jun 2;10:1187163. doi: 10.3389/fmed.2023.1187163. eCollection 2023.
4
Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes.动脉粥样硬化与炎症：通论病理过程学说的启示。
Int J Mol Sci. 2023 Apr 26;24(9):7910. doi: 10.3390/ijms24097910.
5
Long Covid: conceptualizing the challenges for public health.长新冠：对公共卫生挑战的概念化。
J Public Health (Oxf). 2023 Aug 28;45(3):771-779. doi: 10.1093/pubmed/fdac153.
6
Long COVID: the next public health crisis is already on its way.长期新冠：下一场公共卫生危机已然在路上。
Lancet Reg Health Eur. 2023 May;28:100612. doi: 10.1016/j.lanepe.2023.100612. Epub 2023 Mar 11.
7
A review of cytokine-based pathophysiology of Long COVID symptoms.基于细胞因子的长新冠症状病理生理学综述。
Front Med (Lausanne). 2023 Mar 31;10:1011936. doi: 10.3389/fmed.2023.1011936. eCollection 2023.
8
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.既往 SARS-CoV-2 感染对再感染的保护作用：系统评价和荟萃分析。
Lancet. 2023 Mar 11;401(10379):833-842. doi: 10.1016/S0140-6736(22)02465-5. Epub 2023 Feb 16.
9
Transcriptional Insights of Oxidative Stress and Extracellular Traps in Lung Tissues of Fatal COVID-19 Cases.致命性 COVID-19 病例肺部组织中氧化应激和细胞外陷阱的转录组学研究。
Int J Mol Sci. 2023 Jan 31;24(3):2646. doi: 10.3390/ijms24032646.
10
Biomarkers in long COVID-19: A systematic review.新冠长期症状中的生物标志物：一项系统综述。
Front Med (Lausanne). 2023 Jan 20;10:1085988. doi: 10.3389/fmed.2023.1085988. eCollection 2023.
Zotero 插件